ArticleMolecular cancer research : MCR2021

Preclinical Evaluation of Gilteritinib on NPM1-ALK-Driven Anaplastic Large Cell Lymphoma Cells.

Sudhakiranmayi Kuravi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.